Cardiol Therapeutics Statistics Share Statistics Cardiol Therapeutics has 82.65M
shares outstanding. The number of shares has increased by 18.27%
in one year.
Shares Outstanding 82.65M Shares Change (YoY) 18.27% Shares Change (QoQ) 1.28% Owned by Institutions (%) 11.04% Shares Floating 78.7M Failed to Deliver (FTD) Shares 5,330 FTD / Avg. Volume 1.33%
Short Selling Information The latest short interest is 1.72M, so 2.09% of the outstanding
shares have been sold short.
Short Interest 1.72M Short % of Shares Out 2.09% Short % of Float 2.16% Short Ratio (days to cover) 8.11
Valuation Ratios The PE ratio is -3.59 and the forward
PE ratio is -2.39.
Cardiol Therapeutics's PEG ratio is
-0.23.
PE Ratio -3.59 Forward PE -2.39 PS Ratio 0 Forward PS 80.6 PB Ratio 5.33 P/FCF Ratio -5.26 PEG Ratio -0.23
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Cardiol Therapeutics.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 4.52,
with a Debt / Equity ratio of 0.01.
Current Ratio 4.52 Quick Ratio 4.52 Debt / Equity 0.01 Debt / EBITDA n/a Debt / FCF -0.01 Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-2.04M Employee Count 18 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by -49.5% in the
last 52 weeks. The beta is 0.79, so Cardiol Therapeutics's
price volatility has been higher than the market average.
Beta 0.79 52-Week Price Change -49.5% 50-Day Moving Average 1.35 200-Day Moving Average 1.32 Relative Strength Index (RSI) 33.05 Average Volume (20 Days) 399,474
Income Statement
Revenue n/a Gross Profit n/a Operating Income -40.28M Net Income -36.68M EBITDA -40.11M EBIT -40.28M Earnings Per Share (EPS) -0.51
Full Income Statement Balance Sheet The company has 30.58M in cash and 158.53K in
debt, giving a net cash position of 30.42M.
Cash & Cash Equivalents 30.58M Total Debt 158.53K Net Cash 30.42M Retained Earnings -179.25M Total Assets 25.45M Working Capital 17.52M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -25.06M
and capital expenditures -21.29K, giving a free cash flow of -25.08M.
Operating Cash Flow -25.06M Capital Expenditures -21.29K Free Cash Flow -25.08M FCF Per Share -0.35
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
